Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4534036
Max Phase: Preclinical
Molecular Formula: C30H40ClN5O9
Molecular Weight: 613.67
Molecule Type: Unknown
Associated Items:
ID: ALA4534036
Max Phase: Preclinical
Molecular Formula: C30H40ClN5O9
Molecular Weight: 613.67
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCC[C@@H](C(=O)NCNC(=O)c1cccc(-c2ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)c(C)c2)n1)[C@@H](CC)N(O)C=O.Cl
Standard InChI: InChI=1S/C30H39N5O9.ClH/c1-4-6-7-9-21(25(5-2)35(44)17-36)27(39)31-16-32-29(41)23-11-8-10-22(33-23)19-12-13-20(18(3)14-19)28(40)34-24(30(42)43)15-26(37)38;/h8,10-14,17,21,24-25,44H,4-7,9,15-16H2,1-3H3,(H,31,39)(H,32,41)(H,34,40)(H,37,38)(H,42,43);1H/t21-,24+,25-;/m1./s1
Standard InChI Key: QHCSULSRIUITGX-HDFQZRMESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 613.67 | Molecular Weight (Monoisotopic): 613.2748 | AlogP: 2.34 | #Rotatable Bonds: 18 |
Polar Surface Area: 215.33 | Molecular Species: ACID | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.35 | CX Basic pKa: 2.28 | CX LogP: 2.71 | CX LogD: -2.68 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.05 | Np Likeness Score: -0.20 |
1. (2017) Hydroxy formamide derivatives and their use, |
Source(1):